bioAffinity Technologies (BIAF) Competitors $0.99 -0.19 (-15.86%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BIAF vs. JUNE, VIVK, MOBQ, INUV, FLNT, SGRP, PIXY, IZEA, SWVL, and MNYShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Junee (JUNE), Vivakor (VIVK), Mobiquity Technologies (MOBQ), Inuvo (INUV), Fluent (FLNT), SPAR Group (SGRP), ShiftPixy (PIXY), IZEA Worldwide (IZEA), Swvl (SWVL), and MoneyHero (MNY). These companies are all part of the "business services" industry. bioAffinity Technologies vs. Junee Vivakor Mobiquity Technologies Inuvo Fluent SPAR Group ShiftPixy IZEA Worldwide Swvl MoneyHero bioAffinity Technologies (NASDAQ:BIAF) and Junee (NASDAQ:JUNE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Do analysts rate BIAF or JUNE? bioAffinity Technologies presently has a consensus price target of $6.00, suggesting a potential upside of 504.35%. Given bioAffinity Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe bioAffinity Technologies is more favorable than Junee.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Junee 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, BIAF or JUNE? Junee has lower revenue, but higher earnings than bioAffinity Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$9.37M1.65-$7.94M-$0.82-1.21Junee$2.90M17.92N/AN/AN/A Do insiders & institutionals hold more shares of BIAF or JUNE? 1.6% of bioAffinity Technologies shares are held by institutional investors. 35.1% of bioAffinity Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is BIAF or JUNE more profitable? Junee has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -91.22%. Junee's return on equity of 0.00% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-91.22% -205.09% -115.95% Junee N/A N/A N/A Does the media refer more to BIAF or JUNE? In the previous week, bioAffinity Technologies' average media sentiment score of 0.00 equaled Junee'saverage media sentiment score. Company Overall Sentiment bioAffinity Technologies Neutral Junee Neutral Does the MarketBeat Community believe in BIAF or JUNE? bioAffinity Technologies received 1 more outperform votes than Junee when rated by MarketBeat users. CompanyUnderperformOutperformbioAffinity TechnologiesOutperform Votes1100.00% Underperform VotesNo VotesJuneeN/AN/A SummarybioAffinity Technologies beats Junee on 7 of the 11 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.47M$4.20B$5.12B$9.07BDividend YieldN/A1.78%4.91%4.22%P/E Ratio-1.2155.3491.3417.19Price / Sales1.6547.521,117.70116.80Price / CashN/A23.6242.6437.86Price / Book1.953.144.794.78Net Income-$7.94M$139.50M$120.07M$225.60M7 Day Performance6.75%-0.35%-1.90%-1.23%1 Month Performance-19.61%3.18%11.45%3.37%1 Year Performance-32.00%14.18%30.63%16.58% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies2.6923 of 5 stars$0.99-15.9%$6.00+504.4%-37.6%$15.47M$9.37M-1.2110Gap UpHigh Trading VolumeJUNEJuneeN/A$4.19-0.7%N/AN/A$54.37M$2.90M0.00N/APositive NewsVIVKVivakor1.3565 of 5 stars$1.31-5.4%N/A+22.0%$53.52M$59.32M-3.215Positive NewsMOBQMobiquity TechnologiesN/A$3.00-10.4%N/A+2,071.1%$52.19M$1.24M-2.9912INUVInuvo1.4874 of 5 stars$0.36+3.2%$1.00+180.5%+27.8%$50.09M$78.45M-5.7680Analyst ForecastNews CoverageFLNTFluent2.4014 of 5 stars$2.75-2.5%$4.00+45.5%-37.0%$46.41M$261.98M-1.58260Analyst ForecastGap DownSGRPSPAR Group3.775 of 5 stars$1.90-2.6%N/A+95.0%$44.56M$228.87M3.7624,288PIXYShiftPixyN/A$6.53flatN/AN/A$44.12M$15.02M0.0060IZEAIZEA WorldwideN/A$2.56-0.4%N/A+15.6%$43.44M$33.77M-2.72130SWVLSwvl0.3297 of 5 stars$6.38-0.9%N/A+598.9%$43.33M$22.85M0.002Negative NewsGap DownMNYMoneyHero0.9487 of 5 stars$1.07-0.9%N/A-34.5%$41.23M$90.19M-0.32359 Related Companies and Tools Related Companies Junee Competitors Vivakor Competitors Mobiquity Technologies Competitors Inuvo Competitors Fluent Competitors SPAR Group Competitors ShiftPixy Competitors IZEA Worldwide Competitors Swvl Competitors MoneyHero Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BIAF) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.